Rendimiento clínico de biopsia de mapeo guiada por plantilla transperineal para la toma de decisiones terapéuticas en el cáncer de próstata de bajo riesgo

Aus, 2005, EAU guidelines on prostate cancer, Eur Urol, 48, 546, 10.1016/j.eururo.2005.06.001

Jemal, 2009, Cancer statistics, 2009, CA: A Cancer Journal for Clinicians, 59, 225

Schröder, 2012, Prostate-cancer mortality at 11 years of follow-up, N Engl J Med, 366, 981, 10.1056/NEJMoa1113135

Wilt, 2012, Radical prostatectomy versus observation for localized prostate cancer, New Engl J Med, 367, 203, 10.1056/NEJMoa1113162

Andrews, 2014, Five-year follow-up of active surveillance for prostate cancer: A Canadian community-based urological experience, Can Urol Assoc J, 8, E768, 10.5489/cuaj.2186

Barzell, 2007, Appropriate patient selection in the focal treatment of prostate cancer: The role of transperineal 3-dimensional pathologic mapping of the prostate—a 4-year experience, Urology, 70, 27, 10.1016/j.urology.2007.06.1126

Hodge, 1989, Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate, J Urol, 142, 71, 10.1016/S0022-5347(17)38664-0

Rabbani, 1998, Incidence and clinical significance of false-negative sextant prostate biopsies, J Urol, 159, 1247, 10.1016/S0022-5347(01)63574-2

Scattoni, 2007, Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: A critical analysis of the literature, Eur Urol, 52, 1309, 10.1016/j.eururo.2007.08.006

Elabbady, 2006, Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score, Eur Urol, 49, 49, 10.1016/j.eururo.2005.08.013

Sivaraman, 2014, Transperineal template-guided mapping biopsy of the prostate, Int J Urol

Dindo, 2004, Classification of surgical complications: A new proposal with evaluation in a cohort of 6,336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae

Mitropoulos, 2012, Reporting and grading of complications after urologic surgical procedures: An ad hoc EAU guidelines panel assessment and recommendations, Eur Urol, 61, 341, 10.1016/j.eururo.2011.10.033

Maccagnano, 2012, Prostate saturation biopsy following a first negative biopsy: State of the art, Urol Int, 89, 126, 10.1159/000339521

Abouassaly, 2008, Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies, J Urol, 180, 911, 10.1016/j.juro.2008.05.019

Onik, 2008, Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy, Urol Oncol, 26, 506, 10.1016/j.urolonc.2008.03.005

Arumainayagam, 2013, Multiparametric M.R. Imaging for detection of clinically significant prostate cancer: A validation cohort study with transperineal template prostate mapping as the reference standard, Radiology, 268, 761, 10.1148/radiol.13120641

Ahmed, 2012, Transatlantic consensus group on active surveillance and focal therapy for prostate cancer, BJU Int, 109, 1636, 10.1111/j.1464-410X.2011.10633.x

Rubio-Briones, 2014, Obligatory information that a patient diagnosed of prostate cancer and candidate for an active surveillance protocol must know, Actas Urol Esp, 38, 559, 10.1016/j.acuro.2014.02.007

Guijarro, 2015, Changes in Gleason score grading on serial follow-up biopsies in prostate cancer patients undergoing active surveillance, Actas Urol Esp, 39, 139, 10.1016/j.acuro.2014.08.002

Ficarra, 2005, The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy, Eur Urol, 48, 932, 10.1016/j.eururo.2005.08.008

Yamamoto, 2005, Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan, Int J Clin Oncol, 10, 117, 10.1007/s10147-004-0464-7

Berglund, 2008, Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance, J Urol, 180, 1964, 10.1016/j.juro.2008.07.051

Falzarano, 2010, Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: A correlative study and implications for focal therapy, Urology, 76, 682, 10.1016/j.urology.2009.11.067

Barret, 2013, Morbidity of focal therapy in the treatment of localized prostate cancer, Eur Urol, 63, 618, 10.1016/j.eururo.2012.11.057

Sartor, 2008, Evaluating localized prostate cancer and identifying candidates for focal therapy, Urology, 72, S12, 10.1016/j.urology.2008.10.004

Tsivian, 2010, Predicting unilateral prostate cancer on routine diagnostic biopsy: Sextant vs extended, BJU Int, 105, 1089, 10.1111/j.1464-410X.2009.08904.x